Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CHF | -.--% | -.--% | -.--% |
05-22 | UBS Starts Colruyt Coverage With Buy Rating | MT |
05-22 | Colruyt: in the green on broker's comments | CF |
Sales 2024 * | 10.81B 11.75B 10.49B 921B | Sales 2025 * | 11.49B 12.49B 11.15B 979B | Capitalization | 6.01B 6.53B 5.83B 512B |
---|---|---|---|---|---|
Net income 2024 * | 553M 601M 537M 47.1B | Net income 2025 * | 349M 379M 339M 29.72B | EV / Sales 2024 * | 0.58 x |
Net Debt 2024 * | 285M 310M 276M 24.27B | Net Debt 2025 * | 338M 368M 328M 28.82B | EV / Sales 2025 * | 0.55 x |
P/E ratio 2024 * |
6.55
x | P/E ratio 2025 * |
16.4
x | Employees | - |
Yield 2024 * |
4.75% | Yield 2025 * |
3.03% | Free-Float | 24.23% |
Managers | Title | Age | Since |
---|---|---|---|
Stefan Goethaert
CEO | Chief Executive Officer | - | 30/11/12 |
Stefaan Vandamme
DFI | Director of Finance/CFO | - | 31/01/19 |
Jef Colruyt
CHM | Chairman | - | 31/12/93 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rika Coppens
BRD | Director/Board Member | 52 | 30/03/19 |
Director/Board Member | 60 | 31/08/11 | |
Jef Colruyt
CHM | Chairman | - | 31/12/93 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.25% | 530B | |
+13.45% | 37.43B | |
+0.08% | 36.45B | |
+24.43% | 35.77B | |
+10.32% | 29.52B | |
+7.81% | 27.6B | |
-15.35% | 25.7B | |
+9.39% | 18.71B | |
+2.68% | 14.09B |
- Stock Market
- Equities
- COLR Stock
- COLR Stock